Showing results (11-20 of 341) with videos related to
Sort By:
Pageof 35
Biometrical Journal. Biometrische Zeitschrift|February 22, 2021
Correcting the bias of the net benefit estimator due to right-censored observationsJulien Péron, Maryam Idlhaj, Delphine Maucort-Boulch, et al.Statistics in Medicine|January 4, 2023
Individualized Net Benefit estimation and meta-analysis using generalized pairwise comparisons in N-of-1 trialsJoris Giai, Julien Péron, Matthieu Roustit, et al.Swiss Medical Weekly|June 26, 2014
Reduction in the use of diagnostic tests in infants with risk factors for early-onset neonatal sepsis does not delay antibiotic treatmentGilles Duvoisin, Céline Fischer, Delphine Maucort-Boulch, et al.Pancreas|January 11, 2019
The Benefit-Risk Balance of Nab-Paclitaxel in Metastatic Pancreatic AdenocarcinomaJulien Péron, Joris Giai, Delphine Maucort-Boulch, et al.The British Journal of Ophthalmology|June 19, 2016
Correlation in retinal nerve fibre layer thickness in uveitis and healthy eyes using scanning laser polarimetry and optical coherence tomographyDavid Bellocq, Delphine Maucort-Boulch, Laurent Kodjikian, et al.Diabetes Technology & Therapeutics|May 2, 2013
Advanced glycation end products assessed by skin autofluorescence: a new marker of diabetic foot ulcerationJulien Vouillarmet, Delphine Maucort-Boulch, Paul Michon, et al.Biostatistics (Oxford, England)|March 10, 2015
Spatially regularized mixture model for lesion segmentation with application to stroke patientsBrice Ozenne, Fabien Subtil, Leif Østergaard, et al.Hepatology (Baltimore, Md.)|July 7, 2015
World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinomaCatherine de Martel, Delphine Maucort-Boulch, Martyn Plummer, et al.International Journal of Cancer|February 2, 2018
Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwideDelphine Maucort-Boulch, Catherine de Martel, Silvia Franceschi, et al.Journal of the National Cancer Institute|March 7, 2019
Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival BenefitJulien Péron, Alexandre Lambert, Stephane Munier, et al.Pageof 35